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Abstract. A mAb (lE5) that binds the COOH-terminal
region of the 0 subunit of chicken CapZ inhibits the
ability of CapZ to bind the barbed ends of actin fila-
ments and nucleate actin polymerization . CapZ pre-
pared as fusion proteins in bacteria or nonfusion pro-
teins by in vitro translation has activity similar to that
of CapZ purified from muscle. Deletion of the 000H-
terminus of the 0 subunit of CapZ leads to a loss of
CapZ's ability to bind the barbed ends of actin filaments.
A peptide corresponding to the COOH-terminal region
C
HICKEN CapZ is an actin-binding protein that binds
the barbed ends of actin filaments in vitro (9) and
nucleates actin polymerization (5). CapZ is a mem-
ber of the "capping protein family, which are heterodimers
with subunits of 31-36 kD (a) and 28-32 kD (0) (19). Mem-
bers ofthis family have been cloned from chicken (6, 10, 12),
Dictyostelium (15), Xenopus (2), and S. cerevfsiae (1), and
protein has been purified from a wide variety of eukaryotes
(19) . Capping protein purified from chicken muscle (18) has
been called CapZ because it localizes to the Z-line (9), sug-
gesting that it binds the barbed ends of the actin filaments
in the sarcomere. In chicken, the genes encoding muscle
CapZ are also expressed in nonmuscle tissues (6, 12), and
capping protein has been localized to structures that contain
actin filaments in epithelial cells (Schafer, D. A., M. B.
Heintzelman, M. S. Mooseker, and J. A. Cooper; manu-
script submitted for publication). Deletion of the gene for the
ß subunit of capping protein in yeast leads to an alteration
in the actin cytoskeleton (1) .
To analyze the relationship between the structure of CapZ
and its function, specifically its interaction with actin, we
prepared mAbs to CapZ and cloned full-length cDNAs for
CapZ a and 0 into expression vectors. We report here that
a mAb against the COOH-terminal region of CapZ0 inhibits
the ability ofCapZ0 to bind actin, that deletion ofthis region
leads to loss of activity in expressed CapZ, and that this re-
gion on its own binds actin . The results indicate that this re-
gion is an actin-binding site of CapZ.
Materials andMethods
Unless otherwise stated, chemicals were from Sigma Chemical Co. (St.
Louis, MO), solvents were from Fisher Scientific (St. Louis, MO), and
© The Rockefeller University Press, 0021-9525/92/02/923/9 $2 .00
The Journal ofCell Biology, Volume 116, Number 4, February 1992 923-931
of CapZ 0, expressed as a fusion protein, binds actin
monomers. The mAb lE5 also inhibits the binding of
this peptide to actin.
These results suggest that the COOH-terminal region
of the ß subunit of CapZ is an actin-binding site. The
primary structure of this region is not similar to that
of potential actin-binding sites identified in other pro-
teins. In addition, the primary structure of this region
is not conserved across species.
DNA restriction and modifying enzymes were from Promega Biotec (Madi-
son, WI). Protein concentration was determined by the methodof Bradford
with BSA as the standard (4). Recombinant DNA manipulations were per-
formed as described (21).
Bacterial Fusion Protein Constructs
A cDNA for the complete 0 subunit of chicken skeletal muscle CapZ (277
amino acids) was obtained as described (6) and in this study is called pBS-
0(1-277). This cDNA is cloned into the EcoRl site of the pBlueScript
SK(-) (pBS, Stratagene, La Jolla, CA) cloning vector, in frame with
0-galactosidase. pBS-0(1-265) was constructed by digesting pBS-0(1-277)
with Hincll (this restriction enzyme recognition site is at nucleotide 794 of
the 0 subunit cDNA [6]) to excise the 3'region of the coding sequence, the
3'untranslated sequence, andaportion ofthe polylinker. Thelarge fragment
was isolated and religated. An unintentional loss of a base introduced a stop
codon after V265. pBS-0(1-267)/0-gal was constructed identically without
loss of a base, resulting in a 3' fusion protein with vector sequence. This
construction restored the normal residues L266, T267, and R269 but changed
Q26s to S and added additional residues from the vector as shown in Fig. 1.
For expression, the CapZ 0 cDNAs were cloned into the pGex vector
in which CapZ 0 is preceded by glutathione-S-transferase (GST)' (23).
pGex-0(1-277) wasconstructed using the polymerasechain reaction(PCR),
the forwardprimer 1, the reverseprimer 2, and 10 ng ofpBS-0(1-277) tem-
plate DNA. The sequence of oligonucleotide primers is given in Table 1.
The PCR product was digested with BamHI and EcoRI, gel purified, and
ligated into similarly digested pGex-1 to produce pGex-0(1-277). The
BamHl-EcoR1 insert of pGex-0(1-277) was also cloned into similarly
digested pBS vector and designated pBS[pGex-0(1-277)1. pGex-0(1-265)
was constructed by digesting pBS-0(1-265) with KpnI (nucleotide 552 of
the 0 subunit cDNA). The 3' fragment corresponding to the truncated cod-
ing sequence of pBS-0(1-265) was purified and ligated into Kpnl-digested
pBS[pGex-0(1-277)1, which had been gel purifiedto removethe 3' fragment
ofthe completecoding region, to producepBS[pGex-0(1-265)] . pBS[pGex-
0(1-265)1 was digested with XhoI, filled with T4 DNA polymerase,
digested with BamHI, gel purified, and ligated into BamHI and Smal
digested pGex-1 to produce pGex-01(1-265). pGrex-0(1-266) was con-
1. Abbreviations used in this paper: GST, glutathione-S-transferase; PCR,
polymerase chain reaction.
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Figure 1. COON-terminal truncations and peptides of the 0 subunit
ofCapZ . The amino acid sequence ofthe COOH-termini of several
constructs are shown . CapZ 0 sequence is shown in uppercase ; vec-
tor sequence is shown in lower case . mAb IE5 reactivity results are
taken from Fig . 4 . For clarity, pGex-ß(2l3-277) is not included
here ; it was recognized by mAb 1E5 . Termination codon is denoted
by an asterisk.
structed by digesting pGex-0(1-277) with BarnHI and HincH and ligating
the released insert into pGex-1 digested with BamHI and Smal . This con-
struct includes five vector-derived codons after L266 of the 0 subunit, fol-
lowed by a stop codon . pGex-ß(2l3-277) was constructedby digestingpBS-
0(1-277) with SspI (nucleotide 636 ofthe 0 subunit cDNA) and EcoRI, and
purifying and ligating this fragment, which encodes the COOH-terminal 65
amino acids of the 0 subunit, into Smal- and EcoRl-digested pGex3x.
pGex-0(1-212) was constructed by digesting pGex-0(1-277) with BamHI
and SspI, and ligating the fragment encoding the NH2-terminal 212 amino
acids into BamHI- and SmaI-digested pGex-1 . This construct includes four
vector-derived codons following N212 of the 0 subunit, followed by a stop
codon . pGex-ß(2S3-277) was constructed using the PCR with the forward
primer 3, the reverse primer 2, and 10 ng of pBS-0(1-277) template. The
reaction product was digested with BamHI and EcoRI, gel-purified, and
ligated into pGex-1 digested with BamHI and EcoRL pGex-0(264-277) was
constructed using the PCR with the forward primer 4, the reverse primer
2, and 10 ng of pBS-0(1-277) templateDNA . The reaction products were
digested with Bg1II and EcoRl, gel purified, and ligated into BamHI- and
EcoRI-digested pGex3x .
For expression of the a subunit of CapZ, pGex-a2 was constructed.
Al 1916, a full-length CapZ a2 subunit cDNA in pBS with an NcoI site en-
gineeredat the initiating ATG, was digested withNcol and EcoRV torelease
the entire coding sequence . The insert was gel purified and ligated into
BamHI- and Smal-digested pGex-1 withthe annealed NcoI-BamHI adaptor
produced by oligonucleotides 5 and 6.
The 5'and 3'vector-insert boundarieswereverified with oligonucleotide-
primed double-strand dideoxy sequencing using modified T7 polymerase
(United States, Biochemical Corp., Cleveland, OH) and purified plasmid
DNA. To check for PCR-introduced error, the coding sequences of pGex-
0(1-277) and pGex-ß(2S3-277) were sequenced .
XI-1 Blue bacteria were used for all recombinant DNA and subsequent
fusion protein procedures and were always grown at 37° . All bacterial con-
structs were assayed for production of a polypeptide of the expected size
by protein induction (23), SDS-acrylamide gel electrophoresis of total cel-
lular proteins (17), and Coomassie staining of the gel or immunoblotting
(25) . Immunoblots were blocked in 1% BSA and 5% fish gelatin in TTBS
(20mM Tris/HCl, pH 7.5, 0.3M NaCl, 0.01% NaN 3 , 0.05% Tween 20) for
30 min . Primary antibodies were (a) a goat polyclonal antiserum prepared
against purified chicken CapZ and affinity purified against chicken CapZ
or GSTa2 and GST$ immobilized on nitrocellulose (Schafer, D. A .,
M . B. Heintzelman, M . S. Mooseker, and J. A . Cooper, manuscript sub-
mitted for publication) ; (b) preimmune immunoglobulins from the same
animal ; or (c) hybridoma ascites of mouse mAbs that recognize the a sub-
unit (1Bll) and the 0 subunit (1E5) of chicken CapZ (Fig . 2) . Purified Igs
Figure 2 . mAbs IE5 and IB11 recognize
the ß and a subunit of purified CapZ
on immunoblot (lanes 1 and 2), respec-
tively. Both subunits are recognized by
an affinity-purified polyclonal antibody
(lane 3) . Preimmune IgGs from the same
animal (lane 4) do not bind CapZ . Each
lane contains 20 ng of purified chicken
CapZ . Molecular mass standards are in-
dicated in kilodaltons . DF, dye front .
were used at 1.5 Ag/ml in blocking solution, and ascites was diluted 1:10,000
in blocking solution. Secondary antibodies were alkaline phosphatase-
conjugated affinity-isolated swine anti-(goat Igs) or goat anti-(mouse Igs)
(Tago, Burlingame, CA) . Washes were in TTBS ; development was as de-
scribed (13) .
Recombinant Fusion Protein Preparation
Overnight cultures ofthe appropriate bacterial strains were diluted 1:10 into
800 nil offresh LB media, grown withvigorous aeration for 2 h and induced
with 0.1 mM isopropyl-O-D-thiogalactopyranoside for two additional h .
Cultures were chilled on ice for 30 min and centrifuged at 4,500 g for 15
min at 4°C. All subsequent procedures were carried out at 4°C or on ice.
Bacteria were resuspended in 32 ml MTPBS (150 mM NaCl, 16 mM
Na2HP04, 4 mM NaH2PO4, pH 7.4) with 10 mM EDTA, 0.1 mM DTT,
0.1 mM PMSF, 0.1 mM benzamidine, 0.1 mM leupeptin, and 0.1 mM pep-
statin A . Separate bacterial cultures expressing GSTCapZ a and GST
CapZ 0 subunitswere combined atthis point. The suspension was sonicated
to lyse the cells. Urea was added to 1 M and sarcosyl to 0.2% . The lysate
was centrifuged at 32,000g for 20min. The supernatant was decanted, and,
after addition ofTriton X-100 to 1%, mixed with 15 ml glutathione agarose
beads . The mixture was incubated for 1 h with rocking, poured into a
column, and washed sequentially with 10 column volumes ofMTPBS with
1% Triton X-100 and 10 column volumes ofMTPBS. Recombinant protein
was eluted with 20 mM glutathione, 50 mM Tris/HCI, 0.01% NaN3, pH
8.0, concentrated with a Centricon-30 (Amicon Corp ., Danvers, MA) and
chromatographed on a Superose 6 HR gel filtration column (Pharmacia
Fine Chemicals, Piscataway, NJ) in buffer B (50mM KCI, 0.5 mM EDTA,
10mM Tris/HCI, pH 8 .0, 1 mM 2-mercaptoethanol, 0.1 mM PMSF, 0.01%
NaN 3) . The profile included an early and a late peak . The late peak coin-
cided with the elution position of GSTCapZ a or GSTCapZ 0 alone . The
early peak was active ina low-shear viscometry assay, and the latepeak was
not . Theearly peak was pooled and rechromatographed, eluting at the same
early position . This material was used for activity assays and contains ap-
proximately equimolar amounts of GSTCapZ a and GSTCapZ 0 by SDS-
PAGE (Fig . 3) . For purification of GSTa/GSTO(1-266), GSTa/GST
0(1-265), and GSTa/GST0(1-212) heterodimers, the early peak from the
Superose 6 columnwas pooled and rechromatographed andusedforactivity
assays . These preparations contain approximately equimolar amounts of
each subunit by SDS-PAGE (Fig . 3) . For experiments using 000H-
terminal fusion peptides GST0(253-277) and GST0(264-277) as well as
GST alone, the pooled peak fractions from the glutathione agarose column
were dialyzed into buffer B and used without further purification . The pu-
rity of these preparations is shown in Fig . 3 .
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I.CGG CGG ATC CGA TCG AAG GTC GTA TGA GTG ACC AGC AGC TG
2.AAT ACG ACT CAC TAT AG
3.000 CGG ATC CTA TCG AAG GTC GTT GTC AAA AGT ATA AGC AGT
4.AGG AAG ATC TGT CAA GTG TTG ACC CAG
5 . GAT CCC ATC GAA GGT CG
6 . CAT GCG ACC TTC GAT GG
pGex-P(1-277) (UP) . . .NOKYKOLORELSOVLTOROIYIOPDN- +
pBS-ß(1-267)/ß-gol (UP) . . .NOKYKOLORELSOVLTsRggpvpns . . .Io-gal) +
pGex-ß(1-266) (CZß) . . .NOKYKOLORELSOVLglhrd- +
pGex-ß(1-265) (CZß) . . .NOKYKOLORELSOV- -
pGex-ß1253-277) (GST) . . .COKYKOLORELSOVLTOROIYIOPDN- +
pGex-ß(264-277) (GST) . . .pksdIlegrgIcQVLTOR01YIOPON- -Figure 3 . Recombinant proteins used in activity assays . Coomassie
blue-stained SDS-acrylamide gels are shown . (A) Heterodimers of
fusion proteins. Pooled fractions from the gel filtration column ana-
lyzed on a 10% gel . (Lane 1) GST-a2/GST,3(1-277) ; (lane 2)
GST-a 2/GST,3(1-266) ; (lane 3)GST-a2/GST0(1-265) ; (lane 4)
GST-a2/GST,3(1-212) . (B) COOH-terminal peptides as fusion
proteins. Pooled fractions from the glutathione agarose column
analyzed on a 14% gel . (Lane 1) GST,3(253-277) ; (lane 2) GST
,3(264-277) ; (lane 3)GST. Molecular mass standards are indicated
in kilodaltons . DF, dye front .
Proteins
Actin and CapZ were prepared from chicken pectoralis muscle as described
(7, 16) . Pyrene actin was prepared and used in fluorometric assays of actin
polymerization as described (16) . Actin was dialyzed overnight versus
Cat+ or Mgt+-G-buffer (Ca2+-G-buffer: 200 AM ATP, 2mM Tris-HCI, pH
8.0, 100AM DTT, 0.005% NaN3 , 200AM CaC12 ; Mgt+-G-buffer : 100 AM
ATP, 2 mM Tris-HCI, pH 8 .0, 100 AM DTT, 0.005% NaN3, 50 AM
M9C12) and centrifuged at 100,000 g for 1 h before use .
Monoclonal Antibodies
Balb c/J mice were immunized with purified chicken CapZ . Spleen cells
were fused with P3X63 Ag8.653 myeloma cells by the Hybridoma Center
of Washington University. Medium was screened by ELISA and positive
wells were subcloned in soft agar. Hybridomaclones were grown as ascites .
mAb from ascites and mouse IgG from normal serum were purified by
affinity chromatography on protein A-Sepharose (14) and anion exchange
chromatography (Mono Q ; Pharmacia Fine Chemicals) and dialyzed into
PBS (0.137 M NaCl, 2 .6 mM KCI, 1.5 mM KH2P04, 8 mM Na2HP04,
0.01% NaN3, pH 7.4) . mAbs 1B11 and IE5 are both IgGI by analysis with
specific antibodies (data not shown) . 1B11 binds CapZ a and IE5 binds
CapZ ß by inununoblot (Fig . 2) .
Assayof Capping Activity by Inhibition of
Filament Depolymerization
Actin filaments for depolymerization experiments were prepared by poly-
merizing actin for 1 h at -30AM in thepresence ofMKEI buffer (100mM
KCI, 2 mM MgC12, 1 mM EGTA, 20mM imidazole/HCI, pH 7.0) . The
actin was diluted to 5.0 AM, mixed, and incubated 1 h to allow equilibration
of monomers and filaments.
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Antibodies. 12 Al of600nM CapZ in buffer B with 0.1 mg/ml BSA was
added to 108 Al mAb at various concentrations in PBS with 0.1 mg/ml BSA
in silanized microfuge tubes and incubated for 1 h . 100Alofthis CapZ/anti-
body solution was added to 2,350 Al Cal'-G-buffer in a fluorometer
cuvette. 60 141 of 5 .0 AM, 70% pyrene-labeled actin filaments was vortexed
for 10 s, and 50 Al was added to the cuvette . The cuvette was stirred for
15 s . The capping activity of each sample was calculated by dividing the
fluorescence at 150 s by the initial fluorescence, and subtracting the fluores-
cence at 150 s due to actin and buffer alone . A standard curve for CapZ
alone was constructed by varying the concentration ofCapZ in the incuba-
tion between 0 and 100 nM .
To determine the effect ofmAb lE5 on CapZ bound to actin filaments,
60 141 of 5.0 AM 70% pyrene-labeled actin filaments in Ca"-G-buffer was
added to 60 Al of 120 nM CapZ in a silanized microfuge tube for 5 min .
A sixfold molar excess of mAb IE5 to CapZ (48 Al of900 nM in PBS) was
added to 2.4 ml Cat+-G-buffer in a fluorometer cuvette . 100 Al of the
CapZ/actin filament solution was added to the cuvette, which was stirred
for 15 s . In a control experiment, CapZ and mAb IE5 were added to Cat+ -
G-buffer in a fluorometer cuvette and preincubated for 5 min . 50 Al of 5 .0
AM pyrene actin filaments was added at t = 0 .
Recombinant Proteins. To determine the capping activity of CapZ mu-
tants expressed as fusionproteins in bacteria, depolymerization assays were
performed with the following changes . 60 Al oftest solution in buffer B was
added to 60 Al of 5.0 yM actin filaments and incubated for 2 min . 100 JAI
was added to 2,240 Al Ca2+-G-buffer in a fluorometer cuvette . The activity
of each sample was calculated as above and divided by the value obtained
for 13 .0nM CapZ (defined as 100% capping activity) . The fractional cap-
ping activity was plotted versus the final concentration of added protein.
The concentration of recombinant protein required for 50% maximal cap-
ping activity was determined from this plot .
Nucleation Assay
The effect ofantibodies on the nucleation activity of CapZ was assayed by
incubating 70 Al of 1 .8AM CapZ in buffer B with 0.1 mg/ml BSA plus 961
Al of antibody in PBS with 0.1 mg/ml BSA in silanized microfuge tubes for
1 h . 1,207 Al of 10 FM actin monomers (5% pyrene labeled) in Mgt+-G-
buffer was primed for 5 min in a fluorometer cuvette by adding 12 Al of
2 M MgC12 . At t = 0 the CapZ/antibody solution and 250 Al 10x MKEI
buffer were added . The slope of the tangent at the inflection point of the
plot of fluorescence versus time was calculated . To prepare a CapZ standard
curve, this slope minus the slope for actin alone was plotted against the final
concentration ofCapZ . This standard curve was used to determine the frac-
tional CapZ activity in samples containing varying ratios ofmAb to CapZ .
Low-shear Viscometry Assay
Low-shear viscometry assays were performed with a falling-ball apparatus
(18) . Actin was polymerized at high concentration, diluted to 12 AM, and
added to an equal volume oftest solution immediately before entry into the
capillary tube . Apparent viscosities were plotted versus concentration of
added test protein . The relative activity of each CapZ mutant was deter-
mined from these plots by dividing the concentration of added protein that
gave a 50% maximal reduction in viscosity by the concentration of CapZ
required for an equivalent reduction in viscosity.
Critical Concentration Assay
To determine the activity of COON-terminal peptides on the critical con-
centration of actin, 0-3.0 AM actin filaments (5 or 50% pyrene labeled),
were incubated with 0-1.5 AM purified fusion protein in Cal'-G-buffer
with 104mM KCI, 2 MM MgC12, 1 mM EGTA, 20 mM imidazole/HCI,
pH 7.0 . The fluorescence was measured at 24 and 48 h. In a second experi-
ment, 2 .0 AM actin monomers, 5% pyrene labeled, were incubated with
0-14.0 AM purified fusion protein in W'-G-buffer with 100 mM KCI,
2 MM MgC12, 1 mM EGTA, 20 mM imidazole/HCI, pH 7.0.
In Vitro Ranslation
Vectors for in vitro translation were constructed by splicing the coding re-
gion of the a2 or ß subunit of CapZ into the Ncol site ofa plasmid contain-
ing the 475/Jun-D hybrid (kindly provided by Dr. Daniel Nathans, Johns
Hopkins School of Medicine) from which the Jun-D coding sequence had
been removed (Casella, J. F., and M . A . Torres, 1991, manuscript in
preparation) . These constructs result in the substitution of the 5' untrans-
lated sequence of plasmid 475/Jun-D for the 5' untranslated sequences of
925a2, Q(1-277), /3(1-266), and 0(1-265) in pGEM2 vectors (Promega Bio-
tec) . RNA was produced fromthese constructs using the SP6 promoter and
a transcription kit (pGEM Express Core ; PromegaBiotec) . 5 F+g oftemplate
DNA was used per 50-pl reaction . RNA was capped during transcription
with 0.3 mM cap analogue 5'7Me GpppG 5' (Stratagene) . Translation was
carried out innuclease-treated reticulocyte lysate (PromegaBiotec) . A typi-
cal 50-wl reactioncontained 1/4 oftheRNA froma singletranscription reac-
tion for each subunit (combined before translation), 11A1 ofamino acid mix-
ture lacking methionine (final concentration 20 pM), 48U of RNasin, 35
Al reticulocyte lysate, and 50 ACi of 3'S-methionine. The translation mix-
tures were stored at 4°C and used without further purification .
Cosedimentation ofRadiolabeled CapZ Translation
Products with Actin
Approximately 5 Pl of a translation reaction containing 54,000 cpm of
precipitable 31S-methionine-labeled a2-/3(1-277), a2-s(1-266), or a Z -
(3(1-265) cotranslation products was incubated with 70 pl of 12 /AM actin
in polymerizing buffer (0.2mM ATP, 0.2 mM CaC12, 0.5mM 2-mercapto-
ethanol, 0.01 % NaN3, 5mM Tris-HCI, pH 8 .0, 100mM KCI, 2 MM MgC12 ,
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Figure 4 . The epitope of
mAb IE5 is contained within
the COOH-terminal 25 amino
acids ofthe a subunitofCapZ .
Bacterial expressionconstructs
(rows) were probed with pri-
mary antibodies (columns) by
immunoblot . Only the portion
ofthe blot correspondingto the
immunoreactive peptide of the
appropriate size is shown . Ad-
ditionalbands presumably due
to degradation or incomplete
synthesis are seen for several
constructs . Negative controls,
including mAb 1B11 and pre-
immunepolyclonalIgGs, were
performed for each construct
and showed no reactivity (data
not shown) .
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0.05% Triton X-100) . After 15 min, the mixture was layered over 100 Al
ofthe same buffer plus 20% sucrose and centrifuged for 20 min at 100,000
rpm in an Airfuge (Beckman Instruments, Inc., Palo Alto, CA) . After re-
moval of the supernatants and sucrose barriers, the pellets were solubilized
in warm electrophoresis sample buffer containing 2% SDS . The pellets and
25 Al (1/6 of the total) of the supernatant were analyzed on 10% SDS-poly-
acrylamide gels with autoradiography . Experiments were also carried out
in the presence of0.2 AM purified chicken muscle CapZ, 45nMmAb 1115,
or 45nM antivinculinmAb (gift ofDr. Susan Craig, Johns Hopkins Univer-
sity School of Medicine) . Forquantitative analysis, the translation mixtures
were gel filtered over G-25 resin and cosedimented with actin filaments as
described above . The pellets were washed three times with polymerizing
buffer and solubilized in 2% SDS for scintillation counting .
Results
Identification ofmAb 1E5Epitope
COOH-terminal deletions of the0 subunit of chicken CapZ
were constructed using a full-length cDNA clone and two
different expression vectors, pBS and pGex (Fig . 1) . Immu-
noblots were performed on total bacterial lysates containing
the recombinant fusion proteins with mAb lE5 (Fig . 4) . An
affinity-purified polyclonal antibody to the 0 subunit and a
monoclonal antibody to the a subunit of CapZ were used as
positive and negative controls, respectively. A deletion that
removed the last twelve amino acids and introduced a stop
codon, pBS-(3(1-265), abolished recognition by mAb 1115 ;
the same results were obtained with pGex-(3(1-265) and a de-
letion of the COOH-terminal 65 amino acids (data not
shown) . Removal of ten amino acids with continuation of the
polypeptide into vector sequence (pBS-/3(1-267)//3-gal) al-
lowed binding ofmAb 1115, as did removal ofthe COOH-ter-
minal 11 residues with addition of 5 vector-derived amino
acids (pGex-,Q(1-266) ; data not shown) . The COOH-termi-
na165 amino acids (pGex-(3(213-277)) and the COON-ter-
minal 25 amino acids (pGex-/3(253-277)) were recognized
by mAb lE5, but the COOH-terminal 14 amino acids (pGex-
(3(264-277)) were not . All constructs were recognized by the
polyclonal antibody.
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Figure 5 . Inhibition of CapZ's nucleation activity bymAb 1115. (A) CapZ was incubated with varying concentrations ofmAb IE5 or IBll .
The fluorescence of pyrene-labeled actin is plotted versus time . The final CapZ concentration was 50 nM and the final actin concentration
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Effect ofmAb IE5onActin NucleatingActivity
ofCapZ
Capping protein increases the rate of polymerization of
monomeric actin into filaments in a manner consistent with
an increase in the rate of nucleation (5, 11). Preincubation
of CapZ with mAb lE5 inhibited the nucleating activity of
CapZ (Fig. 5 A). Preincubation of CapZ with mAb 1Bll,
which recognizes the a subunit ofCapZ, had no effect on the
nucleating activity.
By using a standard curve relating polymerization rate to
the concentration of CapZ (data not shown), we were able
to quantify the extent of inhibition of CapZ with different
amounts of mAb (Fig. 5 B). 38 nM mAb IE5 led to a 50%
reduction in the nucleating activity of 50 nM CapZ, indicat-
ing a Kd for binding of mAb IE5 to CapZ of -13 nM.
Effect ofmAb1ES onActin Filament CappingActivity
ofCapZ
CapZ binds to the barbed ends of actin filaments and pre-
vents exchange of actin monomers at this end (5, 9). In an
assay that measures the depolymerization of actin filaments
after dilution, CapZ preincubated with mAb IE5 could not
prevent depolymerization ofactin filaments (Fig. 6 A). CapZ
preincubated with mAb 1B11 was still capable of preventing
dilution-induced depolymerization of actin filaments (data
not shown) .
We also created a standard curve for CapZ activity in this
assay using varied amounts of CapZ (data not shown), and
related the effects of the mAbs added to the CapZ activity
(Fig. 6 B). These data indicate a 50% loss of activity when
60 nM CapZ is incubated with 36 nM mAb 1135, which
predicts aKd of N6 nM, which is in reasonably good agree-
ment with the Kd determined by inhibition of actin filament
nucleating activity.
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Figure 6. Inhibition ofCapZ's capping activity by mAb 1135. (A) The capping activity ofCapZ, as measured in an actin depolymerization
assay, is inhibited by preincubation ofCapZ with mAb 1135. 60 nM CapZ was incubated withmAb IE5 atthe indicatedmolarratios. Fluores-
cence ofpyrene-labeled actinversus time is shown. In an identical assay, mAb 1B11 and purified mouse Igs had no effect (data now shown).
(B) Quantitative effect of varying amounts of mAb on 60 nM CapZ. Capping activity was calculatedforcurves like thosein A and converted
to CapZ concentration using a standard curve for CapZ activity (data not shown). (Open circle) mAb 1135; (closed circle) mAb 11311.
E ffectofnL4b 1135 on CapZBound toActinFTi1aments
In the previous experiment, mAb IE5 was preincubated with
CapZ before the actin was added. The results show that mAb
IE5 can bind CapZ and prevent it from capping actin fila-
ments. To determine if mAb IE5 could bind to and remove
CapZ that was already bound to actin filaments, we added
mAb IE5 to actin filaments that had CapZ bound to their
barbed ends. The filaments were diluted to determine
whether they were capped . As assayed in a depolymerization
assay, mAb IE5 did not inhibit CapZ bound to actin fila-
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Figure 7. Effect of mAb lE5 on CapZ bound to actin filaments, as
assayed in a depolymerization experiment. (A) CapZ was incubated
with actinfilaments for 5 min before dilutioninto a cuvette contain-
ing mAb IE5. (B) The same amounts of CapZ and mAb lE5 as in
A were incubated in the cuvette for 5 min before addition of actin
filaments. (C) Actin filaments alone. B was normalized to the same
initial fluorescence as A.All constructs are fusion proteins with GST. NA, not assayed. These results
are derived from data such as those in Fig. 6 (depolymerization assays). The
low-shear viscometry data are not shown. mAb 1 E5 reactivity is derived from
the immunoblots shown in Fig . 4.
ments (Fig. 7 A). In a control experiment under the same
conditions, mAb IE5 did inhibit CapZ if it was added before
actin filaments (Fig. 7 B).
E ffect ofTfruncation of the COOH Terminus of
CapZ ß on Activity ofExpressed Protein
Recombinant a (GSTa2) and ß (GSTß(1-277)) subunits
were made using the pGex expression vectors. These pro-
teins contain GST fused to the NH2 terminus of the CapZ
subunit, which permits purification by affinity chromatogra-
phy. The a and ß subunits bind to each other, permitting
separation ofthe heterodimer from monomerby gel filtration
chromatography. The heterodimeric protein was active in a
depolymerization assay and a low-shear vicometry assay (Ta-
ble 11). GST protein alone was inactive in both assays (data
not shown). On a molar basis the activity of the heterodi-
meric fusion protein in a depolymerization assay was 52 %,
and in a low-shear viscometry assay 36% of the activity of
CapZ purified from chicken muscle. In a depolymerization
assay, the individual a and ß subunits had very little activity
(Table II and Fig. 8).
Recombinant COOH-terminal truncations ofthe ß subunit
made in the pGex vector (Fig. 1) were combined with GST
a2 and tested for activity using the same assays . In general,
activity correlated with mAb 1E5 binding (Table II). GST
a2/GSTß(1-266), which lacks 11 COOH-terminal residues
and has several vector-derived residues, had a small loss of
activity compared to the intact protein, GSTa2/GST
ß(1-277), and was still recognized by mAb 1E5. GST
a2/GSTß(1-265), which lacks 12 COOH-terminal residues
and has no vector-derived residues, had a complete loss of
functional activity, as did GSTa2/GSTß(1-212), which
lacks the COOH-terminal 65 residues. Neither of these two
constructs were recognized by mAb 1E5.
Sedimentation ofIn Vitro Cotranslated Subunits with
Actin Filaments
To confirm the above results (obtained with fusion protein
preparations), we constructed a and ß subunits in an expres-
sion vector lacking a fusion protein. The complete a and ß
subunits, and COOH-terminally truncated ß subunits, were
transcribed and cotranslated in vitro. Binding of heterodi-
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Figure 8. Effect ofrecombinant CapZ heterodimers on depolymer-
ization of actin filaments. The complete CapZ a1ß fusion protein
caps actin filaments, while the individual subunits and the 000H-
terminal 25 amino acids are much less effective at inhibiting de-
polymerization. Curves are (final concentration): (A) 3.4 nM
GST-a2/GSTß(1-277); (B) 9 nM GST-a2 ; (C) 280 nM GST
ß(2S3-277) ; (D) 146 nM GST)3(1-277) ; (E) actin alone. GST
alone was inactive (data not shown). The final actin concentration
was 0.1 AM, 70% pyrene labeled, and the buffer was Cat+-G
buffer.
meric CapZ to actin filaments was assayed in a cosedimenta-
tion assay. Constructs that maintained mAb IE5 binding
(a2/ß(1-277) and a2/ß(1-266)) cosedimented with actin fila-
ments (Fig. 9). A construct that was not recognizedby mAb
IE5 showed marked dimunition in cosedimentation with ac-
tin filaments (a2/ß(1-265), Fig. 9, pellet 5) . Addition of
mAb lE5 or unlabeled CapZ inhibited cosedimentation (Fig.
9, "+" lanes), whileaddition of a mAb that recognizes vincu-
lin had no effect (data not shown). Equal amounts of F-actin
were precipitated with or without added CapZ, as deter-
mined by SDS-PAGE.
In a separate quantitative analysis, varied amounts of unla-
beledmuscle CapZ were added to compete for binding ofthe
labeled translation products. Dixon plots showed that the Kd
of a2/ß(1-266) relative to that of a2/ß(1-277) was 5.5. The
binding of a2/ß(1-265) was not detectable, which implies a
Kd greater than 15 times that of a2/ß(1-277) for these data.
Effectofthe COOH-terminal 25 Amino Acids of
the ß Subunit on the Apparent Critical Concentration
ofActin
These data indicate that the COOH-terminus of CapZ 0
mightbe an actin-binding site. To test this hypothesis, we de-
termined whether the COON-terminal residues of CapZ ß,
prepared as a fusion protein with GST, were able to bind ac-
tin. The COOH-terminal 25 amino acids, as the fusion pro-
tein GST0(253-277), had viscosity-lowering activity in a
low-shear viscometry assay. This activity was abolished by
preincubation with mAb IE5 (data not shown), indicating
that the structure of the peptide is similar to its structure in
native CapZ. However, this fusion protein had very little ac-
tivity in a depolymerization assay (Fig. 8 and Table II).
These results indicate that GST0(253-277) binds actin
but does not cap actin filaments, suggesting that it may bind
actin monomers. To test this hypothesis, we determined the
Table H. Activity of Fusion Proteins in Depolymerization 4
and Low-shear Viscometry Assays
Depolymerization
assay for capping
(% relative CapZ) (%
Low-shear
viscometry
relative CapZ)
mAb IE5
reactivity
3
C C
Muscle CapZ 100 100 + 4)
0 Z. 2
012/0(1-277) 52 36 + y N
a2/ß(1-266) 43 23 + O =
O .e
a2/ß(1-265) <6 <4 - w t0
092/0(1-212) <6 <4 - 1
a2 <3 <3 -
a <0.2 <0.2 +
ß(2ó4-277) NA <0.2 - 0
0(253-277) <0.1 46 +effect of GSTß(2S3-277) on the critical concentration for
actin polymerization . Varying concentrations of actin fila-
ments in Mgt+-F buffer incubated with GST0(253-277) ex-
hibited a decrease in fluorescence, reflecting an increase in
the apparent critical concentration of actin (Fig . 10) . As neg-
ative controls, neither GST alone nor GST0(264-277) had
any effect in this assay, which was predicted from the results
in the previous sections . Similar results were obtained with
50% pyrene-labeled actin (data not shown) . In a second ex-
periment, 21íM actin was incubated with increasing concen-
trations of GST0(253-277) . Complete depolymerization
was observed (Fig . 11), which indicates that GST0(253-
277) can increase the apparent critical concentration to
2 AM . This value is greater than the critical concentration
for the pointed end (0.6-0.71íM [3, 5]), which indicates that
GSTß(2S3-277) does not cap barbed ends .
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0
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FFgure 10 . Effect of the COOH-terminal 25 amino acids of CapZ
0 on the steady-state critical concentration over a range of actin
concentrations. (Closedcircle) buffer B ; (open circle) 1.5 AMGST
0(264-277) ; (opensquare) 0.5AMGSTß(2S3-277) ;closed square,
1.5 AM GSTß(2S3-277) . In a similar experiment, GST protein
alone had no effect on the critical concentration (data not shown) .
Actinwas 5% pyrene labeled and similar results were obtained with
50% pyrene-labeled actin (data not shown) .
The results in both experiments (Figs . 10 and 11) can be
explained by GST0(253-277) binding actinmonomers with
a Kd of 325 nM, which is diagramed in Fig. 11 . Further-
more, the results of Fig . 10 cannot be explained by a model
in which GST0(253-277) caps actin filaments with a single
binding constant, and hence are not consistent with capping
activity.
Discussion
Identificationand Characterization ofthe
Actin-binding Site
mAb IE5 binds to CapZ and inhibits its ability to bind actin
stoichiometrically . CapZ's ability to cap actin filaments, as
measured in a depolymerization assay, and its ability to
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Figure 9 . Sedimentationofac-
tin filaments with radiolabeled
CapZ heterodimers cotrans-
lated in vitro . Heterodimers of
complete a2 and complete and
truncated0cosedimentedwith
actin filaments . The binding
was blocked by CapZ ormAb
1E5. Autoradiography of 10%
SDS-acrylamide gels, repre-
senting theentire pellet and 1/6
the total supernatant . (Lanes
1 and 2) a2/ß(1-277) ; (lanes 3
and 4) a 2/ß(1-266) ; (lanes S
and 6) a2/ß(1-265) . The in-
hibitor is purified muscle CapZ
or mAb lE5 . In a control ex-
periment, a mAb against vin-
culin had no effect (data not
shown) .
Figure 11 . Effect of the COOH-terminal 25 amino acids of CapZ
0 on the steady-state critical concentration over a range of GST
ß(2S3-277) concentrations . The final actin concentration was 2.0
AM, 5% pyrene labeled . Experimental data are the points repre-
sented by filled squares . Prediction based on a model in which
GST0(253-277) binds actin monomers with a Kd of 325 nM is
shown as a solid line .nucleate actin polymerization from monomers are both in-
hibited. mAb IE5 does not bind to CapZ that is bound to an
actin filament and remove it from the filament. These results
indicate that the binding of mAb IE5 and actin to CapZ are
mutually exclusive, perhaps because the binding sites are
overlapping or identical. To test this idea, we located the
binding site of mAb IE5 and then determined whether that
region of CapZ was important for binding actin.
Epitope mapping shows that mAb IE5 binds near the
COOH terminus of CapZ 0. Loss of the terminal 12 residues
leads to loss of binding. In a construct in which several
vector-derived residues are substituted in place ofthe termi-
nal 11 residues, binding is preserved, implying that the struc-
ture of the epitope is restored by these residues. The 000H-
terminal25 residues are sufficient for binding of mAb lE5,
and the COOH-terminal 14 residues are not. Together these
results indicate the COOH-terminal 25 residues are neces-
sary and sufficient for antibody binding.
Deletion of the COOH-terminal 12 residues of the 0 sub-
unit in recombinant expressed CapZ also leads to a loss of
ability to cap actin filaments. In these experiments, both a
and 0 subunits were required for full activity. When both
complete subunits were expressed separately as fusion pro-
teinsand combined into heterodimers, the product was capa-
ble of capping actin filaments, although at a level quantita-
tively less than that of'purified muscle CapZ . Truncation of
the'COOH terminus of CapZ 0 such that mAb IE5 did not
bind led to a nearly complete loss of activity. In an in vitro
translation system that expresses CapZ with no fusion pro-
tein, the expressed heterodimer bound actin filaments with
high affinity. Truncationofthe COOH-terminal region again
led to a total loss of actin binding activity. Taken together,
these results are consistent with the COOH-terminal region
of CapZ 0 being an actin-binding site. An alternative inter-
pretation is that the COON-terminal region of CapZ0 is im-
portant of6rthé'9tructure of an actin binding site, perhaps be-
cause' in three dimensions the COON-terminal region of
CapZ 0 is adjacent to an actin-binding site of native CapZ.
To distinguish between these alternatives, we tested
whether the COOH-terminal region could bind actin on its
own. We prepared a peptide corresponding to the 000H-
terminal25 amino acids of CapZ 0 as a fusion protein. This
protein binds actin monomers based on determinations of its
effect on the apparent critical concentration of actin. Incuba-
tion of this fusion protein with mAb IE5 inhibited its activity
in a low-shear viscometry assay, indicating that the actin-
binding properties of the peptide are due to the same struc-
ture as in the native protein. A fusion protein that included
the COON-terminal 14 amino acids had no effect in the criti-
cal concentration assay or the low-shear viscometry assay.
Implicationsfor theMechanismofCapZBinding
toActin
*e want to emphasize that the COOH-terminal 25 amino
acids, as a fusion protein, does not cap actin filaments as
does CapZ, and that unlike CapZ, the fusion protein is capa-
ble of binding actin monomers. The peptide clearly does not
replicate the interaction of CapZ with actin. We envision two
alternative implications ofthis discrepancy: CapZ has one or
more actin-binding sites. First, ifCapZ has one actin-binding
site, then the peptide may encompass part but not all of the
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actin-binding region. Indeed, the affinity of the peptide for
actin monomers is low (Kd = 325 nM) compared to that of
CapZ for barbed ends of filaments (Kd = 1 nM [5]) . On the
other hand, if CapZ has more than one actin-binding site, the
COOH terminus of the 0 subunit may represent one of these
sites. In this case, the combination of more than one low-
affinity actin monomer-binding site could yield a single high-
affinity actin filament-binding site.
An argument against the multiple-site model is that the
heterodimer lacking the COOH-terminal 12 amino acids of
CapZ 0 (a2/ß(1-265)) does not bind actin in these experi-
ments. No activity was detectable in the functional assay
(low-shear viscometry), whereas the COOH-terminal 25
amino acids has some activity in this assay (Table II).
However, ifthe binding at a second site did not prevent ac-
tin polymerization, this would not have been detected in the
low-shear viscometry assay. Physical binding should not de-
pend on this function . Cosedimentation with filaments was
also undetectable, although the limits of detection of this as-
say were 15-fold, which is not sensitive to exclude a 300-fold
difference in binding constants such as is seen between the
COOH-terminal region (GSTß(2S3-277)) and native CapZ.
Primary Sequence ofthe Actin-binding Site
The primary sequence of the actin-binding site has two in-
teresting features. First, this sequence is not conserved
across species. In general, the0 subunit is highly conserved,
with 50 % identity between yeast and other species, including
chicken, Dictyostelium discoideum, and Caenorhabditis ele-
gans (1, Waddle, J. A., J. A . Cooper, and R. H . Waterston,
unpublished results, 1991). However, no similarity is found
among the species in the COOH-terminal region of the 0
subunit. Therefore, the conventional notion that functionally
important residues are conserved through evolution may not
hold in this case, or, as noted above, this region may repre-
sent a portion of the actin-binding site and additional con-
served residues may be involved .
Second, this site is not similar to actin-binding sites of
other actin-binding proteins, implying that it represents a
novel class of actin-binding sites. We noted previously that
the primary sequences of capping protein alpha and beta
are not similar to those of any other protein (6, 11) . We have
now compared the primary sequence of the COOH-terminal
region of the 0 subunit to the database and to conserved
regions of actin-binding proteins that may represent actin-
binding sites and find no significant similarity. In this analy-
sis we used the actin-binding site of cofilin (27), which is sim-
ilar to regions of thymosin 04 (20) and actobindin (26), and
we used regions of similarity identified (24) in actin, the gel-
solin family, profilin, and DNase I.
One possible feature of similarity may be positive charge.
Basic residues are a prominent feature of the cofilin/thymo-
sin04/actobindin sequences. Capping protein 0 does include
an arginine in the COON-terminal region in approximately
the same position in all four species. In addition, truncation
of CapZ 0 from 277 to 265 residues leads to a loss ofactivity,
but the activity can be partially restored by a different con-
struct (0 [1-266] of Fig. 1 and Table II) in which several vec-
tor-derived residues, including an arginine and a histidine,
follow 0266.
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